Trump Escalates Trade War: 50% Tariffs on Canadian Cars, Trucks and Parts
Trump announces 50% tariffs on Canadian cars, trucks, parts & steel from Jan 1, 2027, after trade talks with Canada collapse. Markets react.
NOTRELOAD AI
Capricor Gets Three Extra Months as FDA Reviews Stronger Upper-Limb Data for Deramiocel
FDA extends Capricor’s Deramiocel BLA review to Nov 22, 2026 after new 24-month HOPE-3 data focused on upper limb function in Duchenne MD.
Wolfe Research Upgrades Janux Therapeutics to Outperform on Upcoming Autoimmune Data
Wolfe Research upgrades Janux Therapeutics to Outperform with a $23 target. Q4 autoimmune data for JANX011 cited as key catalyst, 32% upside.
Morgan Stanley Initiates Q32 Bio at Overweight with $34 Target — 113% Upside Potential
Morgan Stanley initiates Q32 Bio at Overweight ($34 target) as bempikibart matches JAK efficacy in alopecia areata while offering cleaner safety, less monitoring and durability.
Vanda Pharmaceuticals Receives First EU Orphan Designation for Imsidolimab in Generalized Pustular Psoriasis
Vanda Pharmaceuticals receives the first EU orphan designation for imsidolimab to treat rare, life-threatening GPP. FDA decision due Dec 12, 2026.
FDA Places Clinical Hold on REGENXBIO’s Gene Therapy for Hunter Syndrome
FDA places clinical hold on REGENXBIO’s RGX-121 for Hunter Syndrome after asymptomatic spine MRI findings in 5 patients. Patients remain well; no near-term BLA resubmission.